Showing 1 to 2 of 2 results


High-Efficacy Depression Treatment Limited by Access: A Systemic Issue in US Mental Healthcare
A Stanford study showed TMS effectively treats severe depression, but high cost and lack of insurance coverage limit access, highlighting systemic issues in US mental healthcare where innovation outpaces access despite significant investment.
High-Efficacy Depression Treatment Limited by Access: A Systemic Issue in US Mental Healthcare
A Stanford study showed TMS effectively treats severe depression, but high cost and lack of insurance coverage limit access, highlighting systemic issues in US mental healthcare where innovation outpaces access despite significant investment.
Progress
52% Bias Score

TMS: A Revolutionary Treatment for Depression
Transcranial magnetic stimulation (TMS) is a non-invasive, FDA-approved treatment for depression and OCD showing up to 83% response rates, unlike traditional antidepressants with only 27.5% effectiveness in the STAR*D study; insurance coverage is increasing, making it more accessible.

TMS: A Revolutionary Treatment for Depression
Transcranial magnetic stimulation (TMS) is a non-invasive, FDA-approved treatment for depression and OCD showing up to 83% response rates, unlike traditional antidepressants with only 27.5% effectiveness in the STAR*D study; insurance coverage is increasing, making it more accessible.
Progress
56% Bias Score
Showing 1 to 2 of 2 results